Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

Medicine combination for treating stomach and duodenum diseases

A technology of duodenum and composition, which is applied in the field of pharmaceutical preparations, can solve problems such as rapid heart rate, restricted use of elderly patients, difficulty urinating, etc., and achieve the effect of relieving pain and exerting the curative effect of drugs

Inactive Publication Date: 2011-06-15
苏尊玮
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] 1. Anticholinergic drugs such as atropine, anisodamine, and propensine, which are commonly used clinically to relieve spasm and relieve pain in the gastrointestinal tract, often have side effects such as dry mouth, vertigo, and rapid heart rate, especially after taking it. Can cause serious side effects of urinary retention, therefore, the use of these gastrointestinal antispasmodics is often limited in elderly patients
[0005] 2. Among the many Chinese and Western medicines for clinical treatment of stomach diseases, it is still said that there is still a lack of a drug that can both achieve antacid and rapid pain relief, and often only has one of the therapeutic effects
Some compound Chinese medicine preparations tend to have slow analgesic effects without significant antacid effects

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Medicine combination for treating stomach and duodenum diseases
  • Medicine combination for treating stomach and duodenum diseases

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0018] The pharmaceutical composition for the treatment of stomach and duodenal diseases in this embodiment consists of the following components:

[0019] Aluminum magnesium carbonate powder 80%, procaine powder 20%.

[0020] Made into capsules, each containing aluminum magnesium carbonate powder and procaine powder 0.5g in total.

Embodiment 2

[0022] The pharmaceutical composition for the treatment of stomach and duodenal diseases in this embodiment consists of the following components:

[0023] Aluminum magnesium carbonate powder 75%, procaine powder 25%.

[0024] Made into capsules, each containing aluminum magnesium carbonate powder and procaine powder 0.5g in total.

Embodiment 3

[0026] The pharmaceutical composition for the treatment of stomach and duodenal diseases in this embodiment consists of the following components:

[0027] Aluminum magnesium carbonate powder 85%, procaine powder 15%.

[0028] Made into tablets, each containing aluminum magnesium carbonate powder and procaine powder 0.5g in total.

[0029] In order to confirm the therapeutic effect of the pharmaceutical composition of the present invention, and evaluate whether synergistic effect is produced after the combination of the two crude drugs, the inventor has carried out a series of clinical trial observations and comparative studies. The main research methods and results are as follows:

[0030] 1. General information:

[0031] 269 ​​patients were admitted. Among them, there were 156 males and 113 females. The ratio of male to female is 1.38:1. The oldest is 68 years old, the youngest is 15 years old, with an average of 42.5 years old.

[0032] Clinical manifestations: 132 case...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a medicine combination for treating stomach and duodenum diseases, which comprises 75 to 85 % of aluminium magnesium carbonate powder and 15 to 25% of procaine powder. The combination is prepared by combining the aluminium magnesium carbonate powder and the procaine powder to form a new medicine which can rapidly inhibit the activities of acid and pepsin and also can quickly release the pain in patients suffering from stomach diseases; and the combination of the two raw materials of the medicine can produce certain synergistic effect and is favorable for playing the curative effect of the medicine.

Description

technical field [0001] The invention relates to the technical field of pharmaceutical preparations, in particular to a pharmaceutical composition for treating gastric and duodenal diseases. Background technique [0002] Stomach and duodenal diseases Common diseases include gastritis, peptic ulcer, duodenitis and other diseases. The main clinical manifestations are upper abdominal discomfort, burning or pain, anorexia, nausea, vomiting, acid reflux and other symptoms. Various types of gastritis and peptic ulcer are frequently-occurring and common diseases in the world. Literature analysis indicates that the total incidence of peptic ulcer may account for 10-12% of the population. Not only the incidence is high, but also the symptoms have long-term and periodic attacks , easy to relapse after treatment and other characteristics, it is mostly considered as a stubborn and refractory disease, and some patients may even have serious complications such as massive bleeding, ulcer p...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61P1/04A61K31/245A61K33/10
Inventor 苏尊玮谭兴敏
Owner 苏尊玮
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products